Overview

Nasal Antisepsis for C. Auris Prevention

Status:
RECRUITING
Trial end date:
2028-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized, controlled, open-label trial of effect of 10% povidone iodine intranasal antisepsis on the detection of Candida auris.
Phase:
PHASE4
Details
Lead Sponsor:
Mary K Hayden
Collaborators:
RML Specialty Hospital
Rush University Medical Center
Treatments:
Iodophors
Povidone-Iodine